Gang Luo

1.9k citations
68 papers · 1.4k indexed · h-index 21
Topics
Liver Disease Diagnosis and Treatment (6 papers)Spine and Intervertebral Disc Pathology (5 papers)Immunotherapy and Immune Responses (5 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEMolecular and Cellular Biology
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Gang Luo

64 papers receiving 1.4k citations

Peers

Gang Luo
Comparison fields: 5 of 125
  • Molecular Biology 631
  • Surgery 403
  • Oncology 274
  • Cancer Research 259
  • Pathology and Forensic Medicine 200
Replace Andrea Pellacani with:
Andrea Pellacani Italy
Jianping Zhang China
Yunxia Tao China
Li Yin China
Long Long China
Xin Gou China
Lian Duan China
Min Mao China
Min Su China
Yasuharu Niwa Japan
Gang Luo relative to Andrea Pellacani Italy Andrea Pellacani's profile →
Citations per field
00.5×
Andrea Pellacani · 1×
Citations per year

Countries citing papers authored by Gang Luo

Since Specialization
Citations

This map shows the geographic impact of Gang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gang Luo more than expected).

Fields of papers citing papers by Gang Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gang Luo. The network helps show where Gang Luo may publish in the future.

Co-authorship network of co-authors of Gang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Gang Luo. A scholar is included among the top collaborators of Gang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gang Luo. Gang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 9
4 9
5 1
6 11
7 3
8 9
9 7
10 10
11 20
12 38
13 37
14 31
15 1
16 8
17 36
18 31
19
[Inhibition effect and its mechanism of nobiletin on proliferation of lung cancer cells].
6
20 7

About Gang Luo

Gang Luo is a scholar working on Hepatology, Toxicology and Pathology and Forensic Medicine, having authored 68 papers that have together received 1.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Spine and Intervertebral Disc Pathology (5 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Cancer Research (259 citations), Pathology and Forensic Medicine (200 citations) and Oncology (274 citations). Gang Luo has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Shiming Yang, C. Hu, Yong Xin, Hui Dong, Rui Xie, Bo Tang, Yong Qin, Yue Zhou, Bo–Sheng Li and Yufeng Xiao. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026